Star Education Institute celebrates 19th annual day

New Delhi, April 3: Chairman of Lulu Group, Yusuffali MA on Thursday contributed Rs 25 crores to the Prime Minister's Citizen Assistance and Relief in Emergency Situations (PM-CARES) to combat coronavirus.

"I have humbly contributed INR 25 Crores to the PM Cares Fund to support all relief works in India's fight against the COVID-19," Yusuffali said in a tweet.

Last month, Prime Minister Narendra Modi had created PM CARES Fund and appealed to all the countrymen to show their support for the cause.
The prime minister is the chairman of the trust and its members include the defence minister, the home minister and the finance minister.

Bengaluru, Jun 25: Former Karnataka chief minister and Janata Dal (Secular) leader HD Kumaraswamy on Wednesday claimed that there are shortage of beds and ventilators to treat COVID-19 patients in the state.

In a series of tweets, he targetted the Karnataka government on COVID-19 management.

"The state government has failed to provide adequate treatment to those infected with corona. There are no beds and no ventilators to treat more than four thousand patients. Self-induced lockdown is the only solution," he tweeted.

In his subsequent tweet, he said, "Residents of the state, including Bangalore, now have only one way to escape from COVID-19. Stay at home and celebrate yourself as a self-proclaimed lockdown. Money is not more important than life. Your life is in your hands now."

In another tweet, former Chief Minister alleged that the government has fixed Rs 10-15,000 per day for COVID-19 treatment in private hospitals.

"The state government is also saying this indirectly. The 'home remedy' in the home is to stay at home and be safe. The government has fixed Rs 10-15,000 per day for the treatment of this infection in private hospitals. How poor can afford it while upper class can't afford," he tweeted.

"If four members of a family infected with corona, the cost of treatment for a 15-day treatment at a private hospital is Rs 5-6 lakh. Where do the poor bring that Much money? We must save our lives while the government is sitting incapable. This is my concern for the people of the state," he said in another tweet.

In a video message that HD Kumaraswamy demanded the state government to give all kinds of safety and security to the students who are writing the SSLC exam tomorrow.
HD Kumaraswamy also urged students to be careful.

About 8,48,203 students will appear in the Secondary School Leaving Certificate (SSLC) examination tomorrow, said Karnataka Health Minister B Sriramulu on Wednesday.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.